These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 15127417)

  • 1. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.
    Raney RB; Stoner JA; Walterhouse DO; Andrassy RJ; Donaldson SS; Laurie F; Meyer WH; Qualman SJ; Crist WM;
    Pediatr Blood Cancer; 2004 Jun; 42(7):618-25. PubMed ID: 15127417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.
    Ferrari A; Dileo P; Casanova M; Bertulli R; Meazza C; Gandola L; Navarria P; Collini P; Gronchi A; Olmi P; Fossati-Bellani F; Casali PG
    Cancer; 2003 Aug; 98(3):571-80. PubMed ID: 12879475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
    Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
    Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?
    Blakely ML; Lobe TE; Anderson JR; Donaldson SS; Andrassy RJ; Parham DM; Wharam MD; Qualman SJ; Wiener ES; Grier HE; Crist WM
    J Pediatr Surg; 1999 May; 34(5):736-41; discussion 741-2. PubMed ID: 10359174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
    J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoma of the prostate: a single institutional review.
    Janet NL; May AW; Akins RS
    Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
    Smith LM; Anderson JR; Coffin CM
    Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
    Wolden SL; Lyden ER; Arndt CA; Hawkins DS; Anderson JR; Rodeberg DA; Morris CD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1071-6. PubMed ID: 26581144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.
    Arndt CA; Hawkins DS; Meyer WH; Sencer SF; Neglia JP; Anderson JR
    Pediatr Blood Cancer; 2008 Jan; 50(1):33-6. PubMed ID: 17091486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV.
    Rodeberg D; Arndt C; Breneman J; Lyden E; Donaldson S; Paidas C; Andrassy R; Meyer W; Wiener E
    J Pediatr Surg; 2005 Jan; 40(1):256-62. PubMed ID: 15868594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
    J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of surgery for nonmetastatic abdominal rhabdomyosarcomas: a report from the Italian and German Soft Tissue Cooperative Groups Studies.
    Cecchetto G; Bisogno G; Treuner J; Ferrari A; Mattke A; Casanova M; Dall'Igna P; Zanetti I; Volpato S; Siracusa F; Scarzello G; Boglino C; Carli M;
    Cancer; 2003 Apr; 97(8):1974-80. PubMed ID: 12673726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyosarcoma in children--a ten year review.
    Bradford WB; Jose BO; Butler D; Lindberg RD; Paris K; Spanos WJ; Patel CC; Bertolone SJ
    J Ky Med Assoc; 1998 Oct; 96(10):399-402. PubMed ID: 9803061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
    J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible benefits of high-dose chemotherapy as intensive consolidation in patients with high-risk rhabdomyosarcoma who achieve complete remission with conventional chemotherapy.
    Matsubara H; Makimoto A; Higa T; Kawamoto H; Takayama J; Ohira M; Yokoyama R; Beppu Y; Takaue Y
    Pediatr Hematol Oncol; 2003; 20(3):201-10. PubMed ID: 12637216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of rhabdomyosarcoma at the National Cancer Center Hospital].
    Beppu Y; Fukuma H; Chuma H; Ise T; Ohira M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1603-13. PubMed ID: 3592704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating Pediatric soft tissue sarcomas in a country with limited resources: the experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala.
    Antillon F; Castellanos M; Valverde P; Luna-Fineman S; Garrido C; Serrato T; Rodriguez-Galindo C; Casanova M; Ferrari A
    Pediatr Blood Cancer; 2008 Dec; 51(6):760-4. PubMed ID: 18680154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival for children with parameningeal rhabdomyosarcoma: results from the AIEOP soft tissue sarcoma committee.
    Bisogno G; De Rossi C; Gamboa Y; Sotti G; Ferrari A; Dallorso S; Donfrancesco A; Cecchetto G; Calderone M; Gandola L; Rosolen A; Carli M
    Pediatr Blood Cancer; 2008 Jun; 50(6):1154-8. PubMed ID: 18300319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.